CAPTRUST FINANCIAL ADVISORS - HAEMONETICS CORP ownership

HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 259 filers reported holding HAEMONETICS CORP in Q2 2021. The put-call ratio across all filers is 1.00 and the average weighting 0.1%.

Quarter-by-quarter ownership
CAPTRUST FINANCIAL ADVISORS ownership history of HAEMONETICS CORP
ValueSharesWeighting
Q3 2023$969,435
+27.1%
10,822
+20.8%
0.00%
+33.3%
Q2 2023$762,599
+418.8%
8,957
+298.1%
0.00%
+200.0%
Q2 2022$147,000
-0.7%
2,250
-3.6%
0.00%0.0%
Q1 2022$148,000
+59.1%
2,335
+33.4%
0.00%0.0%
Q4 2021$93,000
-38.8%
1,750
-18.8%
0.00%0.0%
Q3 2021$152,000
+10.9%
2,155
+5.1%
0.00%0.0%
Q2 2021$137,000
-38.6%
2,050
+2.0%
0.00%
-50.0%
Q1 2021$223,000
+1293.8%
2,010
+1388.9%
0.00%
Q4 2020$16,000
+33.3%
1350.0%0.00%
Q3 2020$12,000
+500.0%
135
+440.0%
0.00%
Q2 2020$2,000
-33.3%
250.0%0.00%
Q3 2019$3,0000.0%250.0%0.00%
Q2 2019$3,000250.00%
Other shareholders
HAEMONETICS CORP shareholders Q2 2021
NameSharesValueWeighting ↓
BEACONLIGHT CAPITAL, LLC 95,033$8,511,0002.84%
Advantage Alpha Capital Partners LP 100,170$8,971,0002.10%
Nitorum Capital, L.P. 395,635$35,433,0001.82%
Summit Creek Advisors LLC 127,600$11,428,0001.68%
Bridge City Capital, LLC 40,559$3,632,0001.67%
AEGON ASSET MANAGEMENT UK PLC 520,408$46,603,0001.05%
Jackson Square Partners, LLC 2,298,190$205,825,0001.03%
Parkman Healthcare Partners LLC 30,147$2,700,0000.76%
TEALWOOD ASSET MANAGEMENT INC 9,154$820,0000.54%
AMERICAN CAPITAL MANAGEMENT INC 159,145$14,253,0000.52%
View complete list of HAEMONETICS CORP shareholders